… pancreatic ductal adenocarcinoma to identify opportunities for targeted intervention toward
improving survival. … However, with improvements in systemic therapy for PDAC, it may be time …

… Cochrane library databases were systematically searched to identify eligible studies that
compare recurrence patterns between patients who had NAT (followed by resection) with those …

… on disease free survival (DFS) in patients with resected pancreatic ductal adenocarcinoma
… of adjuvant chemotherapy on 2-year survival in patients with resected pancreatic ductal …

… This network meta-analysis demonstrates that chemotherapy with S1 or mFFX is superior
to GemCap for adjuvant treatment for PDAC, improves survival after surgical resection and …

… survival after surgery for pancreatic ductal adenocarcinoma (… study, was therefore to provide
a systematic review with meta-… overall survival in pancreatic cancer patients after potentially …

… A parallel could be made between CRS and HIPEC for PDAC with the evolving literature
on its role in patients with gastric adenocarcinoma (GA), for which long-term survival following …

… Pooled resection rates calculated in the present systematic review and meta-analysis were
77.4, 60.6, and 22.2 per cent for potentially resectable, borderline resectable, and locally …

… investigated the survival after disease recurrence. … after resection, and yearly thereafter.
Recurrence was considered as the first site of recurrence and was classified as local or systemic …

… to undergo potentially curative surgery. Long-term survival after resection with adjuvant …
has implications for optimizing therapy such as systemic therapy for distant metastasis or …

… therapeutic effect and minimize type II statistical error due to small sample sizes, this study
… to systematically review the literature regarding long-term outcomes (5-year overall survival […